New Zealand Clinical Trial Company Conducts Study Showing Kiwis have Strong Immune Response to Pfizer Vaccine
The findings of a new clinical study, Ka Mātau, Ka Ora, sponsored by the Malaghan Institute of Medical Research and undertaken by New Zealand’s leading clinical trial company Pacific Clinical Research Network (PCRN), have revealed a near-universal strong immune response amongst Kiwis vaccinated with the PfizerNBiotec vaccine. PCRN Medical Director Dr Michael Williams said “It […]
Pencarrow private equity takes significant stake in two NZ clinical research companies
Two of New Zealand’s leading clinical research companies, Lakeland Clinical Trials Group and Southern Clinical Trials Group, have partnered with Pencarrow Private Equity, which has acquired a significant stake in both organisations. Following this investment, Lakeland Clinical Trials (LCT) and Southern Clinical Trials (SCT) have consolidated into one entity which will operate as PCRN Ltd […]
PCRN Welcomes 3 New Facilities
Pacific Clinical Research Network is thrilled to welcome 3 new facilities to its Lakeland Clinical Trials Group, expanding the network’s total clinical trial locations to 16. The new facilities include Lakeland Clinical Trials Wellington, Anteris Clinical Research and Department of Medicine Trust Lakes DHB. Lakeland Clinical Trials Wellington, based at the Upper Hutt Health Centre, […]
New Study into Pfizer-BioNTech COVID-19 Vaccine to Provide Unique NZ Data
A clinical study getting underway in Rotorua and Christchurch will provide valuable information on how our unique population responds to the Pfizer-BioNTech COVID-19 vaccine. The study, ‘Ka Mātau, Ka Ora’ (from knowledge comes wellbeing), is being led by Vaccine Alliance Aotearoa New Zealand – Ohu Kaupare Huaketo (VAANZ) and is being undertaken to inform the […]
